SARTORIUS AG VZ - DE0007165631 (Stock)
Stuttgart
| Price | Diff.% | Date & Time | Bid volume | Bid | Ask | Ask volume |
|---|---|---|---|---|---|---|
191,60 EUR
|
0,4456% | 28.07.2025 19:40 | 131,00 | 191,65 | 192,90 | 130,00 |
| Contact | |
|---|---|
|
Sartorius AG Otto-Brenner-Strasse 20 37079, Goettingen, DE |
| Phone | +49-551-308-0 |
| Fax | +49-551-308-3289 |
| info@sartorius.com | |
| Internet | http://www.sartorius.com |
| IR Contact/PR Contact | Andreas Wiederhold/- |
| Symbol | SRT3 |
| End of financial year | 31.12.2025 |
| Issued capital | 12.130.818.830,20 EUR |
| Shareholders | |
|---|---|
| Armira Partners GmbH & Co. KG | 50,09% |
| Bio-Rad Laboratories, Inc. | 34,69% |
| Sartorius AG | 8,57% |
| Norges Bank Investment Management | 3,39% |
| Herbst Karin Sartorius | 2,29% |
| Carmignac UK Ltd. | 0,27% |
| ProfitlichSchmidlin AG | 0,27% |
| Freefloat | 0,17% |
| APG Asset Management NV | 0,13% |
| Asset Management One Co., Ltd. | 0,08% |
| Keskinäinen Eläkevakuutusyhtiö Ilmarinen | 0,05% |
| Board | |
|---|---|
| Dr. Michael Grosse | Chairman of Managing Board |
| Rene Faber | Member of Executive Committee |
| Dr. Florian Funck | Member of Executive Committee |
| Dr. Alexandra Gatzemeyer | Member of Executive Committee |
| Dr. Lothar Kappich | Chairman of Supervisory Board |
| Hermann Jens Ritzau | Member of Supervisory Board |
| Ilke Panzer | Member of Supervisory Board |
| Manfred Zaffke | Member of Supervisory Board |
| Petra Kirchhoff | Member of Supervisory Board |
| Sabrina Wirth | Member of Supervisory Board |
| Frank Riemensperger | Member of Supervisory Board |
| Dietmar Müller | Member of Supervisory Board |
| Annette Becker | Member of Supervisory Board |
| Dr. Klaus Rüdiger Trützschler | Member of Supervisory Board |
| Dr. Daniela Favoccia | Member of Supervisory Board |
| Dr. David Ebsworth | Member of Supervisory Board |
| Activity Description |
|---|
|
Sartorius AG engages in the provision of solutions for biopharmaceutical research. It operates through following divisions: Bioprocess Solutions (BPS), and Lab Products and Service (LPS). The Bioprocess Solutions division focuses on single-use solutions, helps customers manufacture biotech medications and vaccines safely and efficiently. The Lab Products and services division serves the needs of laboratories performing research and quality control at pharma and biopharma companies and those of academic research institutes. The company was founded by Florence Sartorius, Sr. in 1870 and is headquartered in Goettingen, Germany. |
© 2000 - 2025 UniCredit Bank Austria AG. Please read our terms and conditions
Implemented and powered by FactSet
Fond data is provided from Mountain-View Data Gmbh
Austria-HomePage Version 2.0.54
